Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
0.5610
+0.0069 (1.25%)
At close: Sep 10, 2026, 4:00 PM EDT
0.5610
0.00 (0.00%)
After-hours: Sep 10, 2026, 4:04 PM EDT
Bone Biologics Employees
Bone Biologics had 2 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,445,535
Market Cap
1.55M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2024 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2023 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2022 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2021 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Jaguar Health | 47 |
| Scinai Immunotherapeutics | 45 |
| Virax Biolabs Group | 26 |
| Silexion Therapeutics | 14 |
| Decoy Therapeutics | 11 |
| Jupiter Neurosciences | 5 |
| Oragenics | 3 |
BBLG News
- 2 days ago - Bone Biologics Expands Trial Sites - GlobeNewsWire
- 7 days ago - Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 24 days ago - Bone Biologics announces extended shelf life for rhNELL-1 protein - TheFly
- 4 weeks ago - Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1 - GlobeNewsWire
- 7 weeks ago - Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities - GlobeNewsWire
- 7 weeks ago - Bone Biologics files to sell 6.46M shares of common stock for holders - TheFly
- 2 months ago - Bone Biologics prices $9.0M offering at $1.42 per share. - TheFly
- 2 months ago - Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire